L3VLUP
ProSign in

CNMD in the 13F filings

Conmed Corp · CUSIP 207410101

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Jun 2024
the date the book describes
Filed
15 Aug 2024
latest of these filings; the earliest 13 Aug 2024
Managers listing it
4
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q1 2024 and Q2 2024; 4 listed it in both
Shares listed
1,938,962
combined, among listed positions
Reported value
$134m
combined, at the quarter end

Among the 94 comparable managers: 2 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing CNMD in Q2 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

4 of 4 holders

ActionFiling
Capital Research Global Investors1,709,441$118munder 0.1%Added+248,64713 Aug 2024 (the filing on sec.gov)
Tudor Investment Corp108,321$7.5munder 0.1%Trimmed-5,11014 Aug 2024 (the filing on sec.gov)
PDT Partners LLC64,000$4.4m0.42%Added+51,81515 Aug 2024 (the filing on sec.gov)
GAMCO Investors Inc57,200$4.0munder 0.1%Trimmed-20013 Aug 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2024 to Q2 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
3 in Q3 2024 to 1 in Q2 2026

Tracked managers listing it, at least.

0510152014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CNMD by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20135$73mn.a.n.a.
Q3 20134$49mn.a.n.a.
Q4 20134$56mn.a.n.a.
Q1 20145$44mn.a.n.a.
Q2 20145$28mn.a.n.a.
Q3 20143$34mn.a.n.a.
Q4 20142$40mn.a.n.a.
Q1 20153$92mn.a.n.a.
Q2 20153$132mn.a.n.a.
Q3 20153$121mn.a.n.a.
Q4 20153$112mn.a.n.a.
Q1 20163$103mn.a.n.a.
Q2 20165$131mn.a.n.a.
Q3 20164$106mn.a.n.a.
Q4 20163$108mn.a.n.a.
Q1 20174$114mn.a.n.a.
Q2 20173$106mn.a.n.a.
Q3 20173$109mn.a.n.a.
Q4 20174$91mn.a.n.a.
Q1 20185$137mn.a.n.a.
Q2 20185$189mn.a.n.a.
Q3 20185$228mn.a.n.a.
Q4 20187$177mn.a.n.a.
Q1 20197$327mn.a.n.a.
Q2 20199$366mn.a.n.a.
Q3 20198$326mn.a.n.a.
Q4 201910$362mn.a.n.a.
Q1 202011$175mn.a.n.a.
Q2 202011$206mn.a.n.a.
Q3 202010$208mn.a.n.a.
Q4 20206$180mn.a.n.a.
Q1 20217$171mn.a.n.a.
Q2 20214$185mn.a.n.a.
Q3 20216$173mn.a.n.a.
Q4 20213$179mn.a.n.a.
Q1 20226$233mn.a.n.a.
Q2 20225$180mn.a.n.a.
Q3 20225$153mn.a.n.a.
Q4 20225$209mn.a.n.a.
Q1 20235$268mn.a.n.a.
Q2 20233$345mn.a.n.a.
Q3 20237$301mn.a.n.a.
Q4 20234$318m22
Q1 20246$133m41
Q2 20244$134m22
Q3 20243$119m02
Q4 20244$115m21
Q1 20253$109m20
Q2 20254$95m21
Q3 20255$58m31
Q4 20254$43m219
Q1 20262$34m1217
Q2 20261$27m1213

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CNMD and LLY →CNMD and JNJ →CNMD and VRTX →Choose a stock to compare with CNMD →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CNMD, latest filings →Back to the 13F Explorer →